EQT backs out of takeover bid for UK's Oxford Biomedica
Feb 25 (Reuters) - Private equity group EQT EQTAB.ST said on Wednesday it had decided not to proceed with a takeover offer for Oxford Biomedica OXB.L, sending the British cell and gene therapy manufacturer's shares down nearly 10%. (Reporting by Ankita Bora in Bengaluru; Editing by Shreya Biswas) ((Ankita.Bora@thomsonreuters.com;))